60 DEGREES PHARMACEUTICALS, INC. (SXTP)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, 60 DEGREES PHARMACEUTICALS, INC. reported revenue of $1.01M, up 65.5% from the prior year. The company ran a net loss, with a net margin of -732.5% and a gross margin of 22.3%. It held $5.37M in total assets against $1.99M in total liabilities.
Key ratios (FY2025)
22.3%
Gross margin
-771.6%
Operating margin
-732.5%
Net margin
-217.9%
Return on equity
+65.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.01M | $607.6K | $253.6K | $223.2K | — |
| Cost of Revenue | $781.7K | $384.8K | $474.6K | $432.4K | — |
| Gross Profit | $223.8K | $222.8K | -$221.0K | -$209.2K | — |
| Operating Income | -$7.76M | -$9.72M | -$5.15M | -$1.75M | — |
| Net Income | -$7.37M | -$7.95M | -$3.77M | -$6.18M | — |
| EPS (Diluted) | $-11.73 | $-74.17 | $-59.18 | $-2.61 | — |
| Total Assets | $5.37M | $5.76M | $7.78M | $1.30M | — |
| Total Liabilities | $1.99M | $1.80M | $2.99M | $25.45M | — |
| Shareholders' Equity | $3.38M | $3.96M | $4.80M | -$24.15M | -$18.15M |
| Cash & Equivalents | $1.51M | $1.66M | $2.14M | — | — |
| Operating Cash Flow | -$6.85M | -$5.65M | -$4.54M | -$1.01M | — |
| Capital Expenditures | $139.9K | $103.8K | $57.6K | — | — |
| Shares Outstanding | 670.2K | 113.7K | 66.3K | 2.37M | — |